Procalcitonin is expressed in osteoblasts and limits bone resorption through inhibition of macrophage migration during intermittent PTH treatment
Anke Baranowsky Antonia Donat Jack Winneberger Lana Rosenthal Paul K?hli Cordula Erdmann Melanie Fuchs Karl-Heinz Frosch Serafeim Tsitsilonis Michael Amling Thorsten Schinke Denise Jahn Johannes Keller Shan Jiang Timur Yorgan Peter Ludewig Jessika Appelt Kai K.Albrecht Ellen Otto Paul Knapstein
骨研究(英文版)2022,Vol.10Issue(1):107-121,15.
骨研究(英文版)2022,Vol.10Issue(1):107-121,15.
Procalcitonin is expressed in osteoblasts and limits bone resorption through inhibition of macrophage migration during intermittent PTH treatment
Procalcitonin is expressed in osteoblasts and limits bone resorption through inhibition of macrophage migration during intermittent PTH treatment
摘要
引用本文复制引用
Anke Baranowsky,Antonia Donat,Jack Winneberger,Lana Rosenthal,Paul K?hli,Cordula Erdmann,Melanie Fuchs,Karl-Heinz Frosch,Serafeim Tsitsilonis,Michael Amling,Thorsten Schinke,Denise Jahn,Johannes Keller,Shan Jiang,Timur Yorgan,Peter Ludewig,Jessika Appelt,Kai K.Albrecht,Ellen Otto,Paul Knapstein..Procalcitonin is expressed in osteoblasts and limits bone resorption through inhibition of macrophage migration during intermittent PTH treatment[J].骨研究(英文版),2022,10(1):107-121,15.基金项目
This study was funded by grants from the Else-Kr?ner-Fresenius-Stiftung(EKFS 2017_A22),the German Research Foundation(DFG KE 2179/4-1),and the Berlin Institute of Health to JK (EKFS 2017_A22)
from the Hertie-Stiftung(Hertie Academy of Clinical Neuroscience) (Hertie Academy of Clinical Neuroscience)
and the German Research Foundation(DFG ()
grant numbers:DFG FOR 2879[project LU 1924/1-])to PL. Open Access funding enabled and organized by Projekt DEAL. ()